December 22, 2025

Henry Schein, Inc. (HSIC): Exploring Analyst Consensus and Growth Potential in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC), a leader in the healthcare sector, is drawing the attention of investors as a stalwart in the medical distribution industry. With..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Unpacking the Upside Potential in Transformative Biotech

In the dynamic world of biotechnology, Akero Therapeutics, Inc. (NASDAQ: AKRO) has been capturing investor attention with its focused strategy on developing groundbreaking treatments for metabolic..

Vaxcyte, Inc. (PCVX) Investor Outlook: Exploring a Potential 98% Upside in Biotechnology

Investors and analysts alike are taking a keen interest in Vaxcyte, Inc. (PCVX), a burgeoning force in the biotechnology sector with a market capitalization of $6.08..

Alcon Inc. (ALC) Stock Analysis: Unveiling a 15% Potential Upside in Eye-Care Innovation

Alcon Inc. (NYSE: ALC), a global leader in the eye care sector, stands as a formidable player in the healthcare industry, with an impressive market cap..

Avidity Biosciences, Inc. (RNA) Stock Analysis: Biotechnology Innovator with 434% Revenue Growth Awaits Investor Attention

Avidity Biosciences, Inc. (NASDAQ: RNA) is a promising name in the biotechnology sector, captivating investor attention with its impressive revenue growth and innovative RNA therapeutic solutions...

Chemed Corp (CHE) Stock Analysis: Valuation Insights and 31.91% Potential Upside

Investors with a keen interest in the healthcare sector may find Chemed Corp (NYSE: CHE) a compelling prospect, particularly given its significant potential upside of 31.91%...

Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Innovator with Strong Buy Ratings and Revenue Growth

Krystal Biotech, Inc. (NASDAQ: KRYS) has emerged as a leading player within the biotechnology sector, captivating investor interest with its innovative approach to genetic medicine. Based..

Cytokinetics, Incorporated (CYTK) Stock Analysis: Unveiling a 31.54% Potential Upside in Biotech

Cytokinetics, Incorporated (NASDAQ: CYTK) is making waves in the biotechnology sector, presenting a compelling opportunity for investors seeking exposure to cutting-edge developments in muscle activators and..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing a 19.61% Potential Upside in the Healthcare Sector

Investors in the healthcare sector may want to keep a close eye on RadNet, Inc. (NASDAQ: RDNT), a key player in the diagnostics and research industry...

Revolution Medicines, Inc. (RVMD): Investor Outlook on a Promising Precision Oncology Play with Strong Buy Ratings

Revolution Medicines, Inc. (NASDAQ: RVMD) has caught the attention of investors with its strong foothold in the biotechnology sector, particularly in the niche area of precision..

Summit Therapeutics Inc. (SMMT) Stock Analysis: An 83.78% Potential Upside in Biotech

Investors with an eye on the healthcare sector may find Summit Therapeutics Inc. (NASDAQ: SMMT) an intriguing prospect, especially given its significant potential upside of 83.78%...

Mettler-Toledo International, Inc. (MTD): Investor Outlook with a 7.19% Upside Potential

Mettler-Toledo International, Inc. (NYSE: MTD), a prominent player in the healthcare sector, specifically in diagnostics and research, has caught the eye of investors with its robust..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Strong Buy Ratings Signal 17.75% Potential Upside

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a promising player in the biotechnology sector, is capturing investor attention with its robust pipeline focused on central nervous system (CNS)..

Guardant Health, Inc. (GH) Stock Analysis: Precision Oncology Leader with 12% Upside Potential

Guardant Health, Inc. (GH), a pioneering company in precision oncology, is making waves in the healthcare sector with its innovative approach to diagnostics and research. Headquartered..

Waters Corporation (WAT): Investor Outlook Highlights Promising 7.49% Upside Potential

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, specializes in diagnostics and research solutions that cater to a variety of markets, including pharmaceutical,..

Oscar Health, Inc. (OSCR) Stock Analysis: Navigating Challenges with a 23.2% Revenue Growth

Oscar Health, Inc. (OSCR), a prominent player in the healthcare technology sector, is making waves with its innovative approach to health insurance. The company operates primarily..

McKesson Corporation (MCK) Stock Report: Analyst Ratings Highlight a 14.52% Upside Potential

For investors with an eye on the healthcare sector, McKesson Corporation (NYSE: MCK) stands out as a formidable player in the medical distribution industry. With a..

BeOne Medicines Ltd. (ONC) Stock Analysis: Unpacking a 27% Potential Upside in the Biotech Sector

For investors with an eye on the biotechnology sector, BeOne Medicines Ltd. (ONC) emerges as a significant player worth consideration. With its roots in Switzerland and..

Bausch + Lomb Corporation (BLCO) Stock Analysis: A Closer Look at Its Valuation Metrics and Growth Potential

Bausch + Lomb Corporation (NYSE: BLCO), a venerable name in eye health since its founding in 1853, has been a crucial player in the Healthcare sector,..

Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: 26% Upside Potential Amidst Analyst Confidence

Prestige Consumer Healthcare Inc. (NYSE: PBH), a notable player in the Healthcare sector, specifically within the Drug Manufacturers – Specialty & Generic industry, has recently caught..

Search

Funds

December 22, 2025

Search

Funds

December 22, 2025

FTSE 100

Funds